AA 115, AA115, AA-115, APG 115, APG115, APG-115, Alrizomadlin, Mdm2
Alrizomadlin (APG-115) is an orally bioavailable MDM2-p53 interaction inhibitor. It demonstrates potent, dose-dependent anti-proliferative activity in TP53 wild-type AML cell lines such as MOLM-13 and induces p53-dependent cell cycle arrest and apoptosis, supporting its investigation in cancer research.